News & Updates

Sofosbuvir easy on the kidneys
Sofosbuvir easy on the kidneys
15 Mar 2022

Use of sofosbuvir-based direct-acting antiviral regimens for treating hepatitis C virus (HCV) in clinical trial participants with chronic kidney disease (CKD) does not appear to worsen estimated glomerular filtration rate levels, according to a study. Furthermore, the drug does not appear to contribute to an increased risk of end-stage renal disease among HCV patients with CKD treated in clinical practice.

Sofosbuvir easy on the kidneys
15 Mar 2022
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022 byStephen Padilla

Polypharmacy (PP) arises in nearly one in five patients with inflammatory bowel disease (IBD), particularly in older adults and those with comorbidity, according to a study, adding that PP can complicate adherence to treatment and therapeutic success.

Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022
L-arginine, tadalafil boost Li-ESWT effect for ED
L-arginine, tadalafil boost Li-ESWT effect for ED
14 Mar 2022 byAudrey Abella

In men with erectile dysfunction (ED), adjuvant daily oral therapy with L-arginine and tadalafil was effective and safe in enhancing the efficacy and duration of benefits of low-intensity extracorporeal shockwave therapy (Li-ESWT), a study has shown.

L-arginine, tadalafil boost Li-ESWT effect for ED
14 Mar 2022